The role of SCD5 in promoting mammary cancer cell survival is consistent with the incomplete response to neoadjuvant chemotherapy observed in breast cancer patients presenting significantly higher levels of the enzyme [31]. This evidence concerns the gene SCD5 and breast cancer.